Episode 21 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 5 - Practical Considerations - How Will FXIa Inhibitors Fit Into Stroke Prevention?
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed
Episode 21 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 5 - Practical Considerations - How Will FXIa Inhibitors Fit Into Stroke Prevention?
-
Narrated by:
-
Written by:
About this listen
Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk.
Launch Date: August 25, 2025
Release Date: August 25, 2025
Expiration Date: July 31, 2026
FACULTY
C. Michael Gibson, MD, MS, MA, FRCP, FAHA, FSCAI, FACC
Interventional Cardiologist
Beth Israel Lahey
CEO
Baim Institute for Clinical Research
Professor of Medicine
Harvard Medical School
Manesh Patel, MD
Richard Sean Stack, M.D. Distinguished Professor
Professor of Medicine
Chief, Division of Cardiology
Duke University Health System
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.